Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Sodium cromoglicate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for Vividrin contains the active substance sodium cromoglicate. This belongs to a group of medicines called anti-allergics. Vividrin is used for the relief and treatment of the eye symptoms of hayfever (which is an allergic condition) such as red, sore, itchy and watery eyes. You must talk to a doctor if you do not feel better or if you feel worse.
e Vividrin Do not use these drops — If you are allergic (hypersensitive) to sodium cromoglicate or any of the other ingredients of this medicine including benzalkonium chloride (listed in section 6). Warnings and precautions — Do not use if the bottle has been opened before you are given it. — Throw the bottle away 1 month after first opening it or if the solution stops looking clear. Other medicines and Vividrin — Tell your pharmacist if you are using, have recently used or might use any other medicines. Pregnancy and breastfeeding — If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Driving and using machines — Vividrin can cause stinging and blurring of vision when first used. Do not drive or operate machinery until proper vision is restored. Vividrin contains benzalkonium chloride This medicine contains 0.00306 mg benzalkonium chloride in each drop (0.0306ml) which is equivalent to 0.1 mg/1 ml. Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back 15 minutes afterwards.
Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor. Vividrin contains Polysorbate Vividrin contains polysorbate which can cause allergic reactions.
Vividrin Always use this medicine exactly as described in this leaflet or as your pharmacist has told you. Check with your pharmacist if you are not sure. If your eyes are no better after 2 days of using the eye drops, see your doctor or pharmacist. If you find you need to use the drops continuously for more than 14 days, then check with your pharmacist or doctor before continuing. Dosage Unless otherwise prescribed, the dose for adults and children over 6 years is 1 or 2 drops into each eye 4 times daily. Apply your eye drops in the following way: 1. Before using your Vividrin Hayfever Eye Drops you should wash your hands. 2. You may find it helps to sit in front of a mirror, so that you can see what you are doing. Tilt your head backwards, gently pull down your lower eyelid and carefully place one or two Vividrin Hayfever Eye Drops in the space between the eyelid and the eye. Take care not to touch the dropper with your eye or fingers. 3. Release the eyelid and blink a few times to make sure the liquid covers the whole surface of the eye. 4. Repeat the procedure with the other eye and then replace the cap on the bottle. If you use more Vividrin than you should If you use more Vividrin than you should contact your doctor or pharmacist. If you forget to use Vividrin Use your drops as soon as you remember and then carry on in the usual way. Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. If you experience any difficulty stop using your drops and talk to your doctor or pharmacist. The following
may occur:
Website: www.mhra.gov.uk/ yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Vividrin Keep this medicine out of the sight and reach of children. — Do not use this medicine after the expiry date which is stated on the carton and label. The expiry date refers to the last day of that month. — Do not use the eye drops more than four weeks after first opening the bottle. Discard any unused medicine after this time. — Do not use this medicine if you notice the solution is cloudy. Store below 25oC. Keep bottle in outer carton to protect from light. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Vividrin contains — The active substance is Sodium Cromoglicate. — The other ingredients are Benzalkonium Chloride, Edetic Acid Disodium Salt, Polysorbate, Sorbitol, Sodium Hydroxide and Purified Water. What Vividrin looks like and contents of the pack Your eye drops are sterile preserved multidose eye drops and are supplied in plastic bottles. Each bottle has a volume of 10.0 ml. The eye drops are a clear solution.
Marketing Authorisation Holder and Manufacturer The Marketing Authorisation Holder is: Bausch & Lomb UK Limited 106 London Road Kingston-Upon-Thames Surrey, United Kingdom KT2 6TN The Manufacturer is: Dr. Gerhard Mann Chem-pharm. Fabrik GmbH Brunsbütteler Damm 165/173 13581 Berlin Germany This leaflet was last revised: August 2024.
Vividrin Hayfever 2 % w/v Eye Drops, solution comes as eye drops. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Vividrin Hayfever 2 % w/v Eye Drops, solution is sodium cromoglicate.
Medicines with the same active substance, strength and form include: Allercrom 2% w/v Eye Drops, Allergy Relief 2% w/v eye drops, Solution, Aspire Hayfever Relief 2% w/v Eye Drops, solution. In total there are 18 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Vividrin Hayfever 2 % w/v Eye Drops, solution, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the relief and treatment of the eye symptoms of hayfever.
Method of Administration:
For topical administration to the eye.
Adults, Elderly and Children over 6 years
One or two drops into each eye four times daily.
Vividrin Hayfever Eye Drops should not be used continuously for more than 14 days except on the advice of a doctor or pharmacist.
Hypersensitivity to the active substance sodium cromoglicate or to any of the excipients listed in section 6.1.
The solution should be discarded 1 month after first opening the bottle or if any turbidity develops. Do not use if the bottle has been opened prior to receipt.
Vividrin Hayfever Eye Drops contains benzalkonium chloride
This medicinal product contains 0.00306 mg benzalkonium chloride in each drop (0.0306ml) which is equivalent to 0.1 mg/ml.
Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. Patients should remove contact lenses before using this medicine and put them back 15minutes afterwards.
Benzalkonium chloride has been reported to cause eye irritation, symptoms of dry eyes and may affect the tear film and corneal surface. Vividrin Hayfever Eye Drops should be used with caution in dry eye patients and in patients where the cornea may be compromised.
Patients should be monitored in case of prolonged use.
Vividrin contains Polysorbate
Vividrin contains polysorbate which can cause allergic reactions.
The carton label and patient information leaflet will state:
• The patient should consult a doctor or pharmacist if symptoms do not start to improve within 48 hours,
• Vividrin Hayfever Eye Drops should not be used continuously for more than 14 days except on the advice of a doctor or pharmacist.
None known.
Pregnancy
Vividrin Hayfever Eye Drops should be used cautiously during pregnancy and lactation. The widespread use of sodium cromoglicate has yet to reveal any adverse effects to mother or child during pregnancy.
Lactation
It is not known whether sodium cromoglicate is excreted in human breast milk but on the basis of its physicochemical properties, this is considered unlikely. There is no information to suggest that the use of sodium cromoglicate has any undesirable effects on the baby.
Transient stinging or blurred vision may occur on instillation. Do not drive or operate machinery until proper vision is restored.
Transient stinging and blurring may occur after instillation, other symptoms of local irritation have been reported rarely.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:
United Kingdom
Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
As sodium cromoglicate is absorbed only to a very limited extent from eye drops, no action other than medical observation should be necessary. In the event of accidental ingestion, symptomatic treatment is recommended.
Ask anything about Vividrin Hayfever 2 % w/v Eye Drops, solution. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.